Research graph
References from Impact of denosumab on bone high-resolution peripheral quantitative computed tomography in hemodialysis patients: a retrospective longitudinal observational study. Local targets link to admitted publications; unresolved targets remain external evidence.
Chronic kidney disease–mineral and bone disorder: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
10.1016/j.kint.2024.11.013 · 2025 · External reference
Early impairment of trabecular microarchitecture assessed with HR-pQCT in patients with stage II-IV chronic kidney disease
10.1359/jbmr.090831 · 2010 · External reference
Evaluation of bone microarchitecture by high-resolution peripheral quantitative computed tomography (HR-pQCT) in hemodialysis patients
10.1007/s00198-011-1890-9 · 2012 · External reference
Correlation of bone mineral density with the histological findings of renal osteodystrophy in patients on hemodialysis
2000 · External reference
Studies of bone morphology, bone densitometry and laboratory data in patients on maintenance hemodialysis treatment
1985 · External reference
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 · External reference
Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study
10.1038/sj.ki.5001754 · 2006 · External reference
Risk factors for hip and vertebral fractures in chronic kidney disease: the CRIC study
10.1093/jbmr/zjae021 · 2024 · External reference
A consensus statement on the management of vertebral fractures in CKD stages G4-G5D
10.1093/ndt/gfaf256 · 2026 · External reference
Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation
10.1016/j.kint.2017.07.021 · 2017 · External reference
An open-label, prospective pilot clinical study of denosumab for severe hyperparathyroidism in patients with low bone mass undergoing dialysis
10.1210/jc.2014-1154 · 2014 · External reference
Effects of denosumab and calcitriol on severe secondary hyperparathyroidism in dialysis patients with low bone mass
10.1210/jc.2015-1259 · 2015 · External reference
Impact of denosumab on cardiovascular calcification in patients with secondary hyperparathyroidism undergoing dialysis: a pilot study
10.1007/s00198-020-05391-3 · 2020 · External reference
Denosumab for low bone mass in hemodialysis patients: a noncontrolled trial
10.1053/j.ajkd.2015.03.012 · 2015 · External reference
Denosumab for dialysis patients with osteoporosis: a cohort study
10.1038/s41598-020-59143-8 · 2020 · External reference
Effects of denosumab and alendronate on bone health and vascular function in hemodialysis patients: a randomized, controlled trial
10.1002/jbmr.3676 · 2019 · External reference
Hypocalcemia and bone mineral changes in hemodialysis patients with low bone mass treated with denosumab: a 2-year observational study
10.1093/ndt/gfaa359 · 2021 · External reference
Effects of bone turnover status on the efficacy and safety of denosumab among haemodialysis patients
10.1038/s41598-022-12029-3 · 2022 · External reference
Lower response to denosumab in diabetes patients on hemodialysis
10.5414/cn110473 · 2022 · External reference
The authors reply
10.1016/j.kint.2018.02.013 · 2018 · External reference
Reproducibility of direct quantitative measures of cortical bone microarchitecture of the distal radius and tibia by HR-pQCT
10.1016/j.bone.2010.05.034 · 2010 · External reference
Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
10.1038/sj.ki.5000414 · 2006 · External reference
Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee
10.1002/jbmr.1805 · 2013 · External reference
Missing observations in bone histomorphometry on osteoporosis: implications and suggestions for an approach
10.1016/s8756-3282(99)00194-5 · 1999 · External reference
Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies
10.1002/sim.6607 · 2015 · External reference
Bone turnover markers in the management of CKD-associated osteoporosis—a European consensus
10.1093/ndt/gfag033 · External reference
Matching methods for causal inference: a review and a look forward
10.1214/09-sts313 · 2010 · External reference
. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2017 · External reference
Bone mineral density and fracture risk in older individuals with CKD
10.2215/cjn.12871211 · 2012 · External reference
Comparison of fracture risk prediction among individuals with reduced and normal kidney function
10.2215/cjn.06040614 · 2015 · External reference
Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients—a single-center cohort study
10.1093/ndt/gfr317 · 2012 · External reference
Retraction statement: bone mineral density predicts fractures in chronic kidney disease
10.1002/jbmr.4421 · 2021 · External reference
Bone mass measurement by DXA should be interpreted with caution in the CKD population with vascular calcification
10.1016/j.bonr.2022.101169 · 2022 · External reference
Effect of denosumab on bone health, vascular calcification, and health-related quality of life in hemodialysis patients with osteoporosis: a prospective observational study
10.3390/jcm13051462 · 2024 · External reference
Long-term effect of denosumab on bone disease in patients with CKD
10.2215/cjn.0000000000000213 · 2023 · External reference
Biopsy vs. peripheral computed tomography to assess bone disease in CKD patients on dialysis: differences and similarities
10.1007/s00198-017-3956-9 · 2017 · External reference
Bone mineral and organic properties in postmenopausal women treated with denosumab for up to 10 years
10.1002/jbmr.4538 · 2022 · External reference
Time-lapse HR-pQCT reliably assesses and monitors local bone turnover in patients with chronic kidney disease
2025 · External reference
Trabecular bone score as a marker of skeletal fragility across the spectrum of chronic kidney disease: a systematic review and meta-analysis
10.1210/clinem/dgad724 · 2024 · External reference
Bone fragility fractures in CKD patients
10.1007/s00223-020-00779-z · 2021 · External reference
